"Cholangitis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both.
Descriptor ID |
D002761
|
MeSH Number(s) |
C06.130.120.200
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cholangitis".
Below are MeSH descriptors whose meaning is more specific than "Cholangitis".
This graph shows the total number of publications written about "Cholangitis" by people in this website by year, and whether "Cholangitis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
1997 | 0 | 1 | 1 |
1999 | 1 | 0 | 1 |
2004 | 1 | 1 | 2 |
2006 | 1 | 0 | 1 |
2008 | 2 | 0 | 2 |
2012 | 1 | 2 | 3 |
2015 | 9 | 0 | 9 |
2016 | 2 | 1 | 3 |
2017 | 1 | 0 | 1 |
2018 | 1 | 1 | 2 |
2021 | 1 | 0 | 1 |
2023 | 1 | 0 | 1 |
2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholangitis" by people in Profiles.
-
Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress? Ann Surg Oncol. 2024 May; 31(5):3062-3068.
-
Editorial: The evolving paradigms and treatments for primary biliary cholangitis-Authors' reply. Aliment Pharmacol Ther. 2024 01; 59(2):282.
-
Characteristics of infections and their risk factors in children with biliary atresia. Clin Res Hepatol Gastroenterol. 2023 04; 47(4):102109.
-
ASGE guideline on the management of cholangitis. Gastrointest Endosc. 2021 08; 94(2):207-221.e14.
-
Trends and risk factors for 30-day readmissions in patients with acute cholangitis: analysis from the national readmission database. Surg Endosc. 2021 01; 35(1):223-231.
-
Inflammation, Active Fibroplasia, and End-stage Fibrosis in 172 Biliary Atresia Remnants Correlate Poorly With Age at Kasai Portoenterostomy, Visceral Heterotaxy, and Outcome. Am J Surg Pathol. 2018 12; 42(12):1625-1635.
-
Biliary Decompression in Perihilar Cholangiocarcinoma Improves Survival: A Single-Center Retrospective Analysis. Dig Dis Sci. 2019 02; 64(2):561-569.
-
Seladelpar (MBX-8025), a selective PPAR-d agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study. Lancet Gastroenterol Hepatol. 2017 10; 2(10):716-726.
-
Preoperative Cholangitis and Future Liver Remnant Volume Determine the Risk of Liver Failure in Patients Undergoing Resection for Hilar Cholangiocarcinoma. J Am Coll Surg. 2016 07; 223(1):87-97.
-
Liver Transplantation for Biliary Atresia: Is There a Difference in Outcome for Infants? J Pediatr Gastroenterol Nutr. 2016 Feb; 62(2):220-5.